| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $31.54M | $36.32M | $43.05M | $41.67M | $21.44M |
| R&D | $19.03M | $22.57M | $27.76M | $29.43M | $11.25M |
| SG&A | $12.52M | $13.76M | $15.28M | $12.24M | $10.18M |
| Operating Income | -$31.54M | -$36.32M | -$43.05M | -$41.67M | -$21.44M |
| Interest Expense | – | $4.66M | $4.21M | $1.32M | $0.00 |
| Tax Expense | -$1.17M | -$869.17K | -$1.41M | -$1.20M | -$4.52M |
| Net Income | -$34.50M | -$37.61M | -$42.94M | -$40.85M | -$16.92M |
| EPS (basic) | -0.7400 | -1.0300 | -1.3900 | -1.4300 | -0.6600 |
| EPS (diluted) | -0.7400 | -1.0300 | -1.3900 | -1.4300 | -0.6600 |
| Shares (diluted) | $46.38M | $36.45M | $30.95M | $28.60M | $25.60M |